Delivery Order SPE2DB20D1100-SPE2DB25FE3E6
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,431.03 delivery order on July 25, 2025, for Mounjaro 12.5 mg/0.5 ml pen injectors, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,265.08 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under the company's...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a completion date of July 30, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,088.36 to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $3,265.08 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 mL pen injections on August 8, 2025, with completion targeted for August 11, 2025. This non-competitive, firm fixed-price delivery order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,360.45 for Mounjaro 15 mg/0.5 ml pen injectors on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pen injectors, valued at $22,549.80 under a firm fixed-price contract type. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive set-aside delivery order. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $2,741.01 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors (0.5 ml units). This non-competitive delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025, and utilizes firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a $4,212.77 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors, with an ultimate completion date of August 11, 2025. This competitive award, issued on a firm fixed price basis, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026). The pharmaceutical distributor,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3E6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,714.68 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injectors on August 27, 2025, with an ultimate completion date of August 28, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and runs through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp regularly supplies the Defense Logistics Agency with a comprehensive range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. This delivery order for Mounjaro, a diabetes medication, aligns with AmerisourceBergen's extensive portfolio of specialty pharmaceutical deliveries through the DLA Medical Supply Chain. The SPE2DX IDC serves as a flexible, global pharmaceutical support vehicle enabling AmerisourceBergen to supply brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/27/25 |